Prenatal and New-Born Genetic Testing Market Pivotal Players: Ariosa Diagnostics (Roche), Berry Genomics, BGI, Biorad, Illumina, Laboratory Corporation of America
The pervasiveness of genetic diseases such as galactosemia, phenylketonuria and severe combined immune deficiency (SCID) in the U.S. will mark the growth of market. Genetic diseases are the major reason for infant mortality in U.S. accounting for around 20% of total annual infant deaths. The mandatory newborn screening programs initiated by the government with screening coverage up to 99% coupled with provision of healthcare insurance coverage will be a major boost to the prenatal and newborn genetic testing market.
View full press release